influenza
virus
continu
pose
pandem
epidem
threat
public
infect
human
highli
pathogen
avian
influenza
viru
associ
mortal
excess
fatal
outcom
viru
infect
associ
high
viral
load
hypercytokinemia
avian
viru
one
precursor
virus
highli
pathogen
viru
preval
circul
viru
quail
southern
china
sever
zoonot
transmiss
case
viru
may
evolv
humanadapt
avian
influenza
viru
pandem
potenti
previous
demonstr
viru
hyperinduc
tumor
necrosi
factor
tnf
alpha
express
primari
monocytederiv
macrophag
pbmac
mediat
mitogen
activ
protein
kinas
mapk
recent
report
includ
show
viru
also
hyperinduc
proinflammatori
cytokin
chemokin
compar
howev
role
mapk
famili
member
tnfalpha
express
pbmac
still
unclear
mapk
signal
pathway
play
key
role
induct
inflammatori
reaction
includ
product
proinflammatori
cytokin
tnfalpha
sinc
uncontrol
cytokin
product
lead
detriment
effect
host
activ
mapk
also
induc
neg
feedback
mechan
regul
immun
respons
henc
mapk
phosphatas
key
player
regul
pro
antiinflammatori
respons
host
report
shown
mapk
protein
phosphatas
type
two
wellknown
neg
regul
defici
mice
suscept
septic
shock
respons
lipopolysaccharid
macrophag
defici
mice
show
prolong
activ
enhanc
product
tnfalpha
constitut
larg
famili
serthr
phosphatas
involv
divers
cellular
function
suppress
activ
upstream
kinas
mapk
signal
pathway
shown
virus
develop
variou
strategi
target
order
counteract
host
antivir
respons
howev
role
cytokin
regul
influenza
viru
infect
report
show
viru
activ
hyperinduc
product
tnfalpha
pbmac
compar
viru
moreov
phosphoryl
level
subsequ
tnfalpha
express
macrophag
increas
treatment
select
inhibitor
okada
acid
oa
interestingli
oa
also
increas
level
phosphoryl
tnfalpha
mrna
macrophag
result
provid
insight
complex
mechan
mapkmedi
cytokin
product
influenza
viru
infect
previou
report
demonstr
avian
influenza
virus
includ
induc
high
level
tnfalpha
product
macrophag
contrast
cell
infect
human
influenza
viru
subtyp
addit
tnfalpha
express
larg
part
mediat
activ
investig
mechan
hyperinduct
tnfalpha
examin
kinet
activ
tnfalpha
express
pbmac
infect
viru
pbmac
mocktreat
infect
multipl
infect
moi
indic
time
point
total
rna
treat
cell
harvest
examin
level
tnfalpha
mrna
use
taqman
gene
express
assay
previous
report
level
tnfalpha
product
cultur
supernat
measur
use
enzymelink
immunosorb
assay
elisa
like
virus
significantli
increas
tnfalpha
level
compar
pbmac
figur
b
examin
phosphoryl
level
jnk
pbmac
use
western
blot
analysi
activ
jnk
h
postinfect
hpi
figur
lane
compar
mocktreat
control
figur
lane
pbmac
figur
lane
moreov
level
phosphoryl
induc
higher
figur
lane
furthermor
examin
role
tnfalpha
induct
use
specif
inhibitor
pbmac
treat
indic
dose
min
infect
viru
level
tnfalpha
mrna
protein
measur
hpi
hpi
respect
notabl
level
tnfalpha
mrna
protein
pbmac
significantli
suppress
dose
depend
manner
figur
e
suppress
effect
activ
shown
supplementari
figur
figur
show
cytotox
effect
pbmac
figur
examin
level
influenza
viru
nucleoprotein
use
western
blot
show
affect
express
level
viral
protein
suggest
interfer
infect
figur
summar
induc
significantli
higher
level
tnfalpha
compar
season
hyperinduct
mediat
investig
involv
neg
regul
upon
influenza
viru
infect
measur
express
catalyt
subunit
pbmac
indic
time
point
show
induc
express
hpi
compar
mocktreat
cell
figur
previou
report
shown
hiv
coronaviru
induc
express
turn
modul
excess
product
cytokin
virusinfect
cell
howev
result
show
express
enhanc
influenza
virus
similar
express
modul
pbmac
figur
result
suggest
regul
express
dispens
activ
influenza
virusinfect
pbmac
whether
activ
modul
infect
examin
activ
cell
use
phosphatas
assay
kit
millipor
billerica
usa
figur
surprisingli
despit
induc
high
level
phosphoryl
activ
increas
compar
mocktreat
cell
activ
induc
abrog
okada
acid
oa
select
inhibitor
nm
figur
oa
revers
noncompetit
inhibitor
serinetheorin
protein
phosphatas
howev
oa
inhibit
activ
nm
wherea
inhibit
tissu
extract
meanwhil
cytotox
oa
pbmac
examin
figur
pbmac
treat
oa
indic
concentr
surviv
treat
cell
measur
mtt
assay
incub
h
result
show
oa
induc
cell
death
pbmac
investig
role
virusactiv
regul
upon
infect
pretreat
pbmac
oa
examin
phosphoryl
level
pbmac
hpi
use
western
blot
analysi
phosphoryl
level
pbmac
enhanc
oa
treatment
dosedepend
manner
figur
lane
contrast
activ
pbmac
oa
treatment
figur
result
show
involv
suppress
activ
cell
examin
effect
oa
tnfalpha
product
shown
figur
oa
increas
level
tnfalpha
mrna
protein
pbmac
dosedepend
manner
howev
oa
induc
tnfalpha
mrna
level
uninfect
pbmac
figur
result
reveal
play
role
damp
tnfalpha
product
pbmac
infect
whether
activ
specif
infect
measur
activ
pbmac
hpi
result
show
also
induc
activ
signific
differ
activ
cell
figur
addit
block
activ
oa
increas
phosphoryl
tnfalpha
mrna
pbmac
figur
c
suggest
activ
specif
infect
signal
cascad
mapk
phosphatas
play
critic
role
regul
proinflammatori
cytokin
product
microbi
infect
prevent
uncontrol
inflammatori
reaction
lead
deleteri
effect
host
previous
report
mediat
part
hyperinduct
tnfalpha
primari
human
blood
macrophag
infect
current
studi
investig
neg
regulatori
mechan
hyperinduct
tnfalpha
influenza
viru
infect
result
show
like
viru
induc
activ
high
level
tnfalpha
product
macrophag
compar
season
viru
moreov
induc
activ
infect
cell
treatment
inhibitor
level
activ
tnfalpha
product
enhanc
suggest
play
role
neg
regul
activ
infect
howev
induc
express
indic
activ
mediat
hand
may
target
upstream
signal
pathway
sinc
also
induc
activ
primari
macrophag
despit
activ
level
phosphoryl
subsequ
tnfalpha
product
still
much
higher
cell
infect
high
level
phosphoryl
rais
question
role
viru
infect
previou
studi
show
facilit
influenza
viru
entri
human
airway
epitheli
cell
howev
signific
differ
level
nucleoprotein
pbmac
hpi
without
treatment
suggest
facilit
viru
entri
primari
human
blood
macrophag
figur
whether
high
level
phosphoryl
contribut
mechan
favor
viru
replic
need
investig
mechan
regul
cytokin
product
influenza
viru
infect
remain
investig
studi
use
okada
acid
inhibit
catalyt
activ
sinc
substrat
specif
determin
combin
regulatori
subunit
conserv
catalyt
subunit
target
regulatori
subunit
involv
suppress
tnfalpha
product
futur
studi
specif
antibodi
phosphoryl
jnk
purchas
cell
signal
technolog
beverli
usa
antibodi
specif
actin
purchas
santa
cruz
biotechnolog
dalla
tx
usa
antibodi
specif
c
subunit
purchas
millipor
specif
inhibitor
okada
acid
purchas
merck
millipor
billerica
usa
human
monocytederiv
macrophag
healthi
donor
hong
kong
red
cross
blood
transfus
servic
prepar
previous
describ
brief
blood
mononuclear
cell
separ
centrifug
purifi
adher
method
monocyt
differenti
rpmi
life
technolog
carlsbad
ca
usa
supplement
heatinactiv
autolog
plasma
differenti
macrophag
obtain
cultur
day
influenza
virus
includ
aquailhong
ahong
grown
canin
kidney
cell
purifi
preadsorpt
elut
turkey
red
blood
cell
viru
infect
determin
titrat
canin
kidney
cell
macrophag
infect
virus
multipl
infect
two
min
supernat
contain
viru
inoculum
remov
cell
incub
macrophag
serumfre
medium
life
technolog
carlsbad
ca
usa
supplement
mgml
penicillin
mgml
streptomycin
mocktreat
control
incub
buffer
parallel
condit
protein
harvest
use
sdslysi
buffer
contain
triton
mm
nacl
mm
ph
mm
edta
mm
egta
ph
sd
mgml
pmsf
aprotinin
mm
sodium
orthovanad
pepstatin
leupeptin
mm
sodium
fluorid
total
rna
extract
trizol
reagent
life
technolog
carlsbad
ca
usa
accord
manufactur
instruct
cdna
synthes
total
rna
oligo
dt
primer
superscript
ii
revers
transcriptas
life
technolog
carlsbad
ca
usa
level
mrna
encod
tnfalpha
assay
taqman
gene
express
assay
life
technolog
carlsbad
ca
usa
supernat
sampl
macrophag
cultur
collect
indic
time
point
infect
irradi
uv
light
level
tnfalpha
measur
specif
elisa
kit
r
system
minneapoli
mn
usa
cell
wash
prechil
pb
incub
phosphatas
lysi
buffer
mm
hepe
glycerol
mm
egta
mm
edta
mm
mm
imidazolehcl
mm
benzamidin
aprotinin
leupeptin
mm
pmsf
ph
ice
min
cell
collect
scraper
sonic
three
time
ice
centrifug
g
min
supernat
collect
protein
concentr
measur
bca
kit
thermo
scientif
waltham
usa
activ
carri
malachit
greenbas
immunoprecipit
phosphatas
assay
kit
millipor
billerica
usa
follow
manufactur
protocol
data
obtain
two
group
differ
treatment
analyz
twotail
pair
student
ttest
statist
signific
p
taken
togeth
result
show
induc
higher
level
tnfalpha
product
virus
hyperinduct
mediat
involv
regul
activ
tnfalpha
product
infect
howev
induc
express
indic
activ
mediat
virusinfect
pbmac
result
may
give
new
insight
control
cytokin
express
influenza
viru
infect
may
provid
inform
develop
therapeut
control
cytokin
dysregul
diseas
process
